Biofermin

Biofermin

Manufacturer:

Hoe Pharma

Distributor:

Zuellig Pharma
Full Prescribing Info
Contents
Non-lyophilised Saccharomyces boulardii CNCM I-1079.
Description
Capsule: Each capsule is required to present a minimum Saccharomyces boulardii CNCM I-1079 of 5.0 x 109 CFU.
Powder for oral suspension: Each sachet is required to present a minimum Saccharomyces boulardii CNCM I-1079 of 5.0 x 109 CFU.
Saccharomyces boulardii CNCM I-1079 250 mg (non-lyophilised yeast cells).
Excipients/Inactive Ingredients: Capsule: Corn Starch, Magnesium Stearate, Silicon Dioxide.
Composition of the capsule shell: Hydroxypropyl methyl cellulose (HPMC).
Powder for oral suspension: Fructose, Banana Flavour, Silicon Dioxide.
Indications/Uses
Antidiarrheal health supplement.
Dosage/Direction for Use
Adult: Take 1 sachet/2 capsules once daily after meal. Consume directly.
Contraindications
Patient having a central venous catheter. Critically ill patients or immunocompromised (altered/weakened immune system) patients due to a risk of fungaemia.
Special Precautions
Capsule: Do not exceed recommended dosage. Do not consume desiccant in the bottle.
Consult a doctor or pharmacist before taking this product if the patient is pregnant or breast feeding.
Storage
Capsule: Store below 25° in a cool dry place, keep away from direct sunlight. Refrigeration is recommended for capsule format.
Powder for oral suspension: Store below 30°C, protect from light and moisture.
MIMS Class
Antidiarrheals
ATC Classification
A07FA02 - saccharomyces boulardii ; Belongs to the class of antidiarrheal microorganisms. Used in the treatment of diarrhea.
Presentation/Packing
Form
Biofermin cap 250 mg
Packing/Price
30's
Form
Biofermin powd for oral susp 250 mg
Packing/Price
(banana flavour) 14 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in